BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,357,545 | +3.5% | 412,628 | 0.0% | 0.22% | -27.5% |
| Q1 2023 | $1,312,157 | -76.7% | 412,628 | -49.2% | 0.30% | -78.0% |
| Q4 2022 | $5,623,385 | +92.1% | 812,628 | +75.7% | 1.36% | +132.8% |
| Q3 2022 | $2,928,000 | +292700.0% | 462,628 | +151085.6% | 0.58% | – |
| Q1 2022 | $1,000 | -50.0% | 306 | +6.6% | 0.00% | – |
| Q4 2021 | $2,000 | -99.9% | 287 | -99.7% | 0.00% | -100.0% |
| Q1 2021 | $3,211,000 | -30.3% | 106,481 | 0.0% | 0.11% | -47.1% |
| Q4 2020 | $4,607,000 | +112.0% | 106,481 | +164.3% | 0.20% | +29.9% |
| Q3 2020 | $2,173,000 | -74.5% | 40,281 | -71.2% | 0.16% | -76.9% |
| Q2 2020 | $8,538,000 | +142.8% | 139,874 | +82.8% | 0.68% | +157.2% |
| Q1 2020 | $3,516,000 | – | 76,498 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |